Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

Authors:

Brian Warnecke, Misako Nagasaka, Mohammed Najeeb Al Hallak, Sahar Bannoura, Andrew Elliott, Balazs Halmos, Dave Hoon, Sourat Darabi, Alex Farrell, Ammar Sukari, Milan Radovich, Emil Lou, George Sledge, Wafik El-Deiry, Asfar Azmi, Chul Kim

Conclusions

  • RCC1 expression is a negative prognostic marker in NSCLC, PC, and CRC
  • Further studies to investigate this at the molecular level may be a potential opportunity for novel targeted drug development
Download Publication